In addition to this, transforming growth factor beta 1 TGF-β1 and insulin-like growth factor 1 IGF-1, stored in the bone matrix and released upon cancer-induced bone resorption by osteoclasts, are responsible for TRPV1 expression and activity upregulation [156,157]. The gene discussed is IGF1; the disease is cancer.